Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice

Brain Research

Volumn 729, Issue 2, 1996, Pages 264-269

  Cosi, Cristina ^a   Colpaert, Francis ^a   Koek, Wouter ^a   Degryse, Anne ^a   Marien, Marc ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Benzamide; C57B1 6 mouse; Cortical noradrenaline; Poly(ADP ribose) polymerase; Striatal dopamine

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 1,5 DIHYDROXYISOQUINOLINE; BENZAMIDE; BENZAMIDE DERIVATIVE; DOPAMINE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NORADRENALIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE DEPLETION; CONTROLLED STUDY; CORPUS STRIATUM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030581308     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00571-9     Document Type: Article

References (29)

1. [1] Banasik, M., Komura, H., Shimoyama, M. and Ueda, K., Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribose) transferase, J. Biol. Chem., 267 (1992) 1569-1575.
2. [2] Basma, A.N., Heikkila, R.E., Saporiti, M.S., Philbert, M., Geller, H.M. and Nicklas, W.J., 1-Methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells is enhanced by preventing glycolysis, J. Neurochem., 58 (1992) 1052-1059.
3. [3] Cleaver, J.E., Bodell, W.J., Borek, C., Morgan, W.F., Schwartz, J.L, Poly(ADP-ribose): spectator or participant in excision repair of DNA damage, In M. Miwa, O. Hayaishi, S. Shall, M. Smulson and T. Sugimura (Eds.). ADP-ribosylation, DNA Repair and Cancer, Proc. Int. Symp. Princess Takamatsu Cancer Res. Fund, 13th, Tokyo, 1982, Jap. Soc. Press, Tokyo, 1983, pp. 195-207.
4. [4] Chan, P., DeLanney, L.E., Irwin, I., Langston, J.W. and Di Monte, D.A., Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain, J. Neurochem., 57 (1991) 348-351.
5. [5] Chan, P., Langston, J.W., Irwin, I., DeLanney, L.E. and Di Monte, D,A., 2-deoxyglucose enhances 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-induced ATP loss in the mouse brain. J. Neurochem., 61 (1993) 610-616.
6. [6] Chiueh, C.C., Miyake, H. and Peng, M.T., Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload as underlying mechanisms involved in MPTP-induced parkinsonism, Adv. Neurol., 60 (1993) 251-258.
7. [7] Cosi, C., Colpaert, F., Koek W. and Marien, M., Benzamide prevents MPTP-induced dopamine neurotoxicity in C57B1/6 mice, Soc. Neurosci. Abstr., 21 (1995) 560.
8. [8] Cosi, C., Suzuki, H., Milani, D., Facci, L., Menegazzi, M., Vantini, G., Kanai, Y. and Skaper, S.D., Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells, J. Neurosci. Res., 39 (1994) 38-46.
9. [9] Cosi, C., Suzuki, H., Facci, L., Milani, D. and Skaper, S.D., Poly(ADP-ribose) polymerase: an early marker of glutamate mediated neuronal death, Soc. Neurosci. Abstr., 18 (1992) 46.
10. [10] Gerlach, M., Riederer, P., Przuntek, H. and Youdim, M.B.H., MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease, Eur. J. Pharmacol. Mol. Pharmacol. Sect., 208 (1991) 273-286.
11. [11] Johnson, G.S., Benzamide and its derivatives inhibit nicotinamide methylation as well as ADP-ribosilation, Biochem. Int., 2 (1981) 611-617.
12. [12] Heikkila, R.E., Manzino, L., Cabbat F.S. and Duvoisin, R.C., Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors, Nature, 311 (1984) 467-469.
13. [13] Hulley, P., Hartikka, J., Abdel'Al, S., Engels, P., Buerki, R.H., Wiederhold, H.K, Müller, T., Kelly, P., Lowe, D. and Lubbert, H., Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivo, Eur. J. Neurosci., 7 (1995) 2431-2440.
14. [14] LeDoux, S.P., Hall, C.R., Forbes, P.M., Patton, N.J. and Wilson, G.L., Mechanisms of nicotinamide and thymidine protection from alloxan and streptozotocin toxicity, Diabetes, 37 (1988) 1015-1019.
15. [15] Marien, M.R., Briley, M. and Colpaert, F., Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice, Eur. J. Pharmacol., 236 (1993) 487-489.
16. [16] Melamed, E., Rosenthal, J., Cohen, O., Globus, M. and Uzzan, A., Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP, Eur. J. Pharmacol., 116 (1985) 179-181.
17. [17] Meldrum, B. and Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease, Trends Pharmacol. Sci., 11 (1990) 379-387.
18. [18] Milam, M.K. and Cleaver, E.J., Inhibitors of poly (adenosine diphosphate-ribose) synthesis: effect on other metabolic processes, Science, 223 (1984) 589-591.
19. [19] Salach, J.I., Monoamine oxidase from beef liver mitochondria: simplified isolation procedure, properties, and determination of its cysteinyl flavin content, Arch. Biochem. Biophys., 192 (1979) 128-137.
20. [20] Schraufstatter, I.U., Hyslop, P.A., Hinshaw, D.B., Spragg, R.G., Sklar, L.A., Cochrane, C.G., Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA, 83 (1986) 4908-4912.
21. [21] Sershen, H., Mason, M.F., Reith, M.E.A., Hashim, A. and Lajtha, A., Effect of amphetamine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice, Neuropharmacology, 25 (1986) 927-930.
22. [22] Sundström, E. and Jonsson, G., Differential time course of protection by monoamine oxidase inhibition and uptake inhibition against MPTP neurotoxicity on central catecholamine neurons in mice, Eur. J. Pharmacol., 122 (1986) 275-278.
23. [23] Tipton, K.F. and Singer, T.P., Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds, J. Neurochem., 61 (1993) 1191-1206.
24. [24] Uchida, K., Takahashi, S., Fujiwara, K., Ueda, K., Nakae, D., Emi, Y., Tsutsumi, M., Shiraiwa, K., Ohnishi, T. and Konishi, Y., Preventive effect of 3-aminobenzamide on the reduction of NAD levels in rat liver following administration of diethylnitrosamine, Jpn. J. Cancer Res. (Gann), 79 (1988) 1094-1100.
25. [25] Ueda, K. and Hayaishi, O., ADP-ribosylation, Annu. Rev. Biochem., 54 (1985) 73-100.
26. [26] Zhang, J., Dawson, V.L., Dawson, T.M. and Snyder, S.H., Nitric oxide activation of poly(ADP-ribose)synthetase in neurotoxicity, Science, 263 (1994) 687-689.
27. [27] Zhang, J., Pieper, A. and Snyder, S.H., Poly(ADP-ribose)synthetase activation: an early indicator of neurotoxic DNA damage, J. Neurochem., 65 (1995) 1411-1414.
28. + neurotoxicity and delays its elimination from the striatum, Brain Res., 501 (1989) 11-22.
29. [29] Weyler, W. and Salach, J.I., Purification and properties of mitochondrial monoamine oxidase type A from human placenta, J. Biol. Chem., 260 (1985) 13199-13207.